Repligen Appoints Dr. Konstantin Konstantinov to Board of Directors
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
📰 Repligen Corp News
Page 9 - Repligen Corp News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Repligen Corp. Real-time updates on events, politics, business and more.
Global Single-use Technologies for Biopharmaceuticals
Dublin, May 27, 2022 (GLOBE NEWSWIRE) -- The "Single-use Technologies for Biopharmaceuticals: Global Markets" report has been added to...
Nordrhein Westfalen United States Netherlands General Aucteq Biosystems Optek Danulat Gmb Levitronix Gmb
Source: globenewswire.com
Outlook on the Single-use Technologies for Biopharmaceuticals Global Market to 2026 - Increasing Demand for Personalized Medicine is Driving Growth
/PRNewswire/ -- The "Single-use Technologies for Biopharmaceuticals: Global Markets" report has been added to ResearchAndMarkets.coms offering. The report...
Nordrhein Westfalen United States Netherlands General Aucteq Biosystems Optek Danulat Gmb Laura Wood
Source: prnewswire.com
Outlook on the Single-use Technologies for Biopharmaceuticals Global Market to 2026 - Increasing Demand for Personalized Medicine is Driving Growth
/PRNewswire/ -- The "Single-use Technologies for Biopharmaceuticals: Global Markets" report has been added to ResearchAndMarkets.coms offering. The report...
Nordrhein Westfalen United States Netherlands General Aucteq Biosystems Optek Danulat Gmb Laura Wood
Source: prnewswire.com
Repligen Corporation to Present at Upcoming Investor Conferences
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
TDOC Q1 Results Lag Estimates, STRM Q4 Revenue Soars 100%, RGEN Trims Revenue Outlook
BEDFORD (dpa-AFX) - The following are some of the companies belonging to the healthcare sector that reported quarterly financial results on Wednesday.1. Viking Therapeutics Inc. (VKTX), a clinical-stage
Health Solutions Inc Therapeutics Inc Entasis Therapeutics Holdings Inc Teladoc Health Inc Hologic Inc Repligen Corp
Source: finanznachrichten.de
Repligen: Q1 Earnings Snapshot
WALTHAM, Mass. (AP) _ Repligen Corp. (RGEN) on Wednesday reported first-quarter profit of $47 million. On a per-share basis, the Waltham, Massachusetts-based company said it had profit of 81 cents.
United States Zacks Investment Research Repligen Corp Wall Street Automated Insights Zacks Investment
Source: apnews.com
Invest in the Fully Mapped Human Genome With This ETF
New research from the Telomere-to-Telomere (T2T) Consortium has completed a challenging 8% of the human genome.
Adam Phillippy It Consortium Franklin Templeton National Human Genome Research Institute Thermo Fisher Scientific Inc Intellia Therapeutics Inc
Source: etftrends.com
Membrane Filters Market Size to Grow by USD 8.83 billion
/PRNewswire/ -- According to the report "Membrane Filters Market by Technology and Geography - Forecast and Analysis 2022-2026", the market will witness a YOY...
Source: prnewswire.com
Protein A Resin Market - Vendor Analysis and Growth Outlook: Exclusive Report from Technavio
/PRNewswire/ -- The Protein A Resin Market report provides a detailed insight into the protein a resin market from 2021 to 2026 and forecasts its growth rate...
Source: prnewswire.com